Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

2.79
BATS BZX Real-Time Price
As of 2:19pm ET
 -0.13 / -4.45%
Today’s Change
2.68
Today|||52-Week Range
18.78
-79.44%
Year-to-Date
Why ImmunoGen, Inc. Bounded Higher Today
Jul 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.92
Today’s open2.93
Day’s range2.79 - 2.93
Volume24,887
Average volume (3 months)1,911,570
Market cap$254.3M
Dividend yield--
Data as of 2:19pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.28%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book7.20

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.62-5.46%
BCRXBioCryst Pharmaceuti...+0.03+0.88%
NSTGNanoString Technolog...+0.37+2.78%
RXDXIgnyta Inc-0.13-2.29%
Data as of 2:21pm ET, 07/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs